4//SEC Filing
Lawton Alison Frances 4
Accession 0000950170-25-076403
CIK 0001690585other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:41 PM ET
Size
5.6 KB
Accession
0000950170-25-076403
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-22+12,500→ 12,500 totalExercise: $18.36Exp: 2035-05-22→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:41 PM ET
- Size
- 5.6 KB